Lezing 'Racing Towards A Cure for Cancer'

Voor wie
Studenten, Medewerkers, Alumni, Bedrijven
Wanneer
17-05-2019 van 16:00 tot 17:00
Waar
UGent-VIB-onderzoeksgebouw, Technologiepark 71, 9052 Zwijnaarde
Voertaal
Engels
Door wie
VIB-UGent Center for Inflammation Research (WE14, WE10, GE35)
Contact
coordination@irc.vib-ugent.be
Website
https://www.irc.ugent.be/index.php?id=calendar
Voeg toe aan mijn agenda

This talk will discuss combination of molecular targeted therapy with immunotherapy for improving precision cancer therapeutics.

Dr. Junxia Min is from the Institute of Translational Medicine, Zhejiang University School of Medicine, China. More information on her talk: The development of molecular targeted therapies led to clinical responses in the majority of cancer patients. To discover novel cancer therapeutic targets, our laboratory has been focusing on applying integrative genomic and functional approaches. However, due to limited durable response of targeted therapy in clinic, we are also interested in developing strategies for molecular immunology. This talk will discuss combination of molecular targeted therapy with immunotherapy for improving precision cancer therapeutics. This is a joint seminar with Dr. Fudi Wang.